| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |